Dr Example
Fertility & IVF; 30+ yrs; personalized.Is robotic prolapse repair right for me
common.months_ago
Weight loss from GLP-1 agonists like Ozempic, Mounjaro, Zepbound, and Wegovy can lead to a phenomenon known as "Ozempic face," characterized by volume loss in the cheeks and sagging skin. Several aesthetic solutions are available to address these concerns. For restoring facial volume, options include hyaluronic acid fillers, newer fillers designed to stimulate natural fat production, and platelet-rich plasma (PRP) which uses a patient's own blood as a filler. To counter skin sagging, non-surgical approaches involve devices such as radiofrequency and ultrasound technologies that promote skin tightening. These treatments offer ways to mitigate the aesthetic side effects of rapid weight loss, allowing individuals to improve their appearance while on GLP-1 agonists.
Ozempic face: A term describing facial volume loss and sagging skin that can occur due to rapid weight loss, often seen in individuals using GLP-1 agonist medications.
GLP-1 agonists: A class of medications, including Ozempic, Mounjaro, Zepbound, and Wegovy, primarily used for weight loss and diabetes management.
hyaluronic acid fillers: Injectable substances commonly used to restore lost facial volume and reduce the appearance of sagging.
platelet-rich plasma: Also known as PRP, this is a natural filler made from a patient's own blood to add volume.
radiofrequency devices: Non-surgical medical devices that use radiofrequency energy to tighten skin.
ultrasound devices: Non-surgical medical devices that use ultrasound energy to tighten skin.